A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice

Dengue viruses (DENV) cause an estimated 390 million infections globally. With no dengue-specific therapeutic treatment currently available, vaccination is the most promising strategy for its control. A wide range of DENV vaccines are in development, with one having already been licensed, albeit wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Choo, Jovin J. Y., Vet, Laura J., McMillan, Christopher L. D., Harrison, Jessica J., Scott, Connor A. P., Depelsenaire, Alexandra C. I., Fernando, Germain J. P., Watterson, Daniel, Hall, Roy A., Young, Paul R., Hobson-Peters, Jody, Muller, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105366/
https://www.ncbi.nlm.nih.gov/pubmed/33963191
http://dx.doi.org/10.1038/s41541-021-00328-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105366/
https://www.ncbi.nlm.nih.gov/pubmed/33963191
http://dx.doi.org/10.1038/s41541-021-00328-1

Ejemplares similares